These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

595 related articles for article (PubMed ID: 2462551)

  • 21. Analysis of efficacy and toxicity of chemotherapy with cisplatin, 5-fluorouracil, methotrexate and leucovorin (PFML) and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck.
    Katori H; Tsukuda M; Taguchi T
    Cancer Chemother Pharmacol; 2007 May; 59(6):789-94. PubMed ID: 17053926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Results of an interdisciplinary study of primary inoperable stage T3 and T4 squamous cell carcinoma of the mouth, oropharynx and hypopharynx].
    Rohrmeier M; Langnickel R; Hilpert P
    HNO; 1987 Jan; 35(1):14-8. PubMed ID: 3558010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Combined therapy of locally advanced squamous epithelial cancers in the area of the head and neck].
    Fountzilas G; Daniilidis J; Kalogera-Fountzila A; Apostolidis T; Vritsios A; Tourkantonis A
    Laryngol Rhinol Otol (Stuttg); 1988 Apr; 67(4):165-70. PubMed ID: 2455206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Induction chemotherapy of carcinomas of the oral cavity and oropharynx. Feasibility study, levels and factors of response to treatment. Apropos of 135 cases].
    Calais G; Goga D; Le Flock O; Ballon G
    Rev Stomatol Chir Maxillofac; 1987; 88(5):359-64. PubMed ID: 2448863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck.
    Shin DM; Glisson BS; Khuri FR; Lippman SM; Ginsberg L; Diaz E; Papadimitrakopoulou V; Feng L; Francisco M; Garden A; Kies MS; Myers J; Clayman G; Hong WK
    Cancer; 2002 Jul; 95(2):322-30. PubMed ID: 12124833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integration of safe initial combination chemotherapy (without cisplatin) with a high response rate and local therapy for untreated stage III and IV epidermoid cancer of the head and neck: 5-year survival data.
    Price LA; MacRae K; Hill BT
    Cancer Treat Rep; 1983 Jun; 67(6):535-9. PubMed ID: 6190557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
    Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
    Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
    Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T
    Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transoral laser resection with staged discontinuous neck dissection for oral cavity and oropharynx squamous cell carcinoma.
    Eckel HE; Volling P; Pototschnig C; Zorowka P; Thumfart W
    Laryngoscope; 1995 Jan; 105(1):53-60. PubMed ID: 7837914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized comparison of two chemotherapy, radiotherapy schemes for stage III and IV unresectable squamous cell carcinoma of the head and neck.
    Merlano M; Rosso R; Sertoli MR; Benasso M; Bacigalupo A; Ardizzoni A; Mereu P; Margarino G; Scala M; Vitale V
    Laryngoscope; 1990 May; 100(5):531-5. PubMed ID: 1691811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.
    Psyrri A; Kwong M; DiStasio S; Lekakis L; Kassar M; Sasaki C; Wilson LD; Haffty BG; Son YH; Ross DA; Weinberger PM; Chung GG; Zelterman D; Burtness BA; Cooper DL
    J Clin Oncol; 2004 Aug; 22(15):3061-9. PubMed ID: 15284256
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neoadjuvant radiochemotherapy and radical resection for advanced squamous cell carcinoma of the oral cavity. Outcome of 134 patients.
    Eich HT; Löschcke M; Scheer M; Kocher M; Bongartz R; Wacker S; Zöller JE; Müller RP
    Strahlenther Onkol; 2008 Jan; 184(1):23-9. PubMed ID: 18188519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: efficacy, toxic effects, and limitations.
    Hanna E; Alexiou M; Morgan J; Badley J; Maddox AM; Penagaricano J; Fan CY; Breau R; Suen J
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):861-7. PubMed ID: 15262764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase II study of induction and adjuvant chemotherapy for squamous cell carcinoma of the head and neck. A long-term analysis for the Illinois Cancer Center.
    Athanasiadis I; Taylor S; Vokes EE; Pelzer HJ; Rademaker A; Mittal BB; Ganzenko N; Blough R; Lester EP; Kies MS
    Cancer; 1997 Feb; 79(3):588-94. PubMed ID: 9028372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Combined surgical flaps for simultaneous reconstruction of the tongue, mouth floor and pharynx in expanded glossectomy within the scope of multi-modal treatment of squamous epithelial cancers of UICC stage IV].
    Schedler MG; Federspil P; Schätzle W
    Laryngorhinootologie; 1993 Nov; 72(11):545-50. PubMed ID: 8305119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concurrent chemotherapy and intensity-modulated radiotherapy for organ preservation of locoregionally advanced oral cavity cancer.
    Pederson AW; Salama JK; Witt ME; Stenson KM; Blair EA; Vokes EE; Haraf DJ
    Am J Clin Oncol; 2011 Aug; 34(4):356-61. PubMed ID: 21633289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term results of a pilot study for the treatment of advanced unresectable head and neck tumors by combination chemotherapy and split course radiotherapy.
    Wong G; Hodson DI; Malaker K
    J Otolaryngol; 1986 Dec; 15(6):377-9. PubMed ID: 2433460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Neo-adjuvant chemotherapy of head and neck cancer].
    Bodemann H; Arnold H; Mann W; Hannich S; Kraft A; Löhr GW
    Dtsch Med Wochenschr; 1986 Jul; 111(28-29):1097-100. PubMed ID: 2426076
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Multidisciplinary treatment of carcinoma of the oropharynx].
    Inuyama Y; Fujii M; Tanaka J; Takaoka T; Hosoda H
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1797-803. PubMed ID: 2439017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Primary cytostatic therapy of progressive squamous cell carcinoma of the oral cavity].
    Bienengräber V
    Arch Geschwulstforsch; 1986; 56(5):353-6. PubMed ID: 2429630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.